Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-α phosphorothioate oligodeoxynucleotide

Molecular Pharmacology

Volumn 50, Issue 2, 1996, Pages 236-242

  Yazaki, Takahito ^a,c   Ahmad, Shakeel ^a   Chahlavi, Ali ^a   Zylber Katz, Ester ^a,d   Dean, Nicholas M ^b   Rabkin, Samuel D ^a   Martuza, Robert L ^a   Glazer, Robert I ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b ISIS PHARMACEUTICALS   (United States)

^c KEIO UNIVERSITY   (Japan)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; PROTEIN KINASE C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER TRANSPLANTATION; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG EFFICACY; DRUG SCREENING; FEMALE; GLIOBLASTOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME;

ANIMALS; BASE SEQUENCE; FEMALE; GLIOBLASTOMA; HUMANS; ISOENZYMES; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NEOPLASM TRANSPLANTATION; OLIGONUCLEOTIDES, ANTISENSE; PROTEIN KINASE C; THIONUCLEOTIDES; TRANSPLANTATION, HETEROLOGOUS;

EID: 0029833019     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Mahaley, M. S. J., C. Mettlin, N. Natarajan, E. R. Laws, and B. B. Peace. National survey of patterns of care for brain tumor patients, J. Neurosurg. 71:826-836 (1989).
2. Hall, W. A., E. P. Flores, and W. C. Low. Antisense oligonucleotides for central nervous system tumors. Neurosurgery 38:376-383 (1996).
3. Ahmad, S., T. Mineta, R. L. Martuza, and R. I. Glazer. Antisense expression of protein kinase Cα inhibits the growth and tumorigenicity of human glioblastoma cells. Neurosurgery 35:904-909 (1994).
4. Nishizuka, Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science (Washington D. C.) 258:607-614 (1992).
5. Blobe, G. C., L. M. Obeid, and Y. A. Hannun. Regulation of protein kinase C and role in cancer biology. Cancer Metast. Rev. 13:411-431 (1994).
6. Glazer, R. I. Protein kinase C in neoplastic transformation and differentiation, in Protein Kinase C (J. F. Kuo, ed.). Oxford University Press, Oxford, UK, 171-198 (1994).
7. Gescher, A. Towards selective pharmacological modulation of protein kinase C: opportunities for the development of novel antineoplastic agents. Br. J. Cancer 66:10-19 (1992).
8. Vertosick, F. T. J. The role of protein kinase C in the growth of human gliomas: implications for therapy. Cancer J. 5:328-331 (1992).
9. Dean, N. M., R. McKay, T. P. Condon, and C. F. Bennett. Inhibition of protein kinase C-α expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters. J. Biol Chem. 269:16416-16424 (1994).
10. Dean, N. M., and R. McKay. Inhibition of protein kinase C-α expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides. Proc. Natl. Acad. Sci. USA 91:11762-11766 (1994).
11. Bennett, C. F., M. Y. Chiang, H. Chan, J. E. E. Shoemaker, and C. K. Mirabelli. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol. Pharmacol. 41:1023-1033 (1992).
12. Skehan, P., R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenney, and M. R. Boyd. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 82:1107-1112 (1990).
13. Martuza, R. L., A. Malick, J. M. Market, K. L. Ruffner, and D. M. Coen. Experimental therapy of human glioma by means of a genetically engineered virus mutant. Science (Washington D. C.) 252:854-856 (1991).
14. Mineta, T., S. D. Rabkin, T. Yazaki, W. D. Hunter, and R. L. Martuza. Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas. Nature Med. 1:938-943 (1995).
15. Crooke, S. T., M. J. Graham, J. E. Zuckerman, D. Brooks, B. S. Conklin, L. L. Cummins, M. J. Greig, C. J. Guinosso, D. Kornbrust, M. Manoharan, H. M. Sasmor, T. Schleich, K. L. Tivel, and R. H. Griffey. Pharmacokinetic properties of several novel oligonucleotide analogs in mice. J. Pharmacol. Exp. Ther. 227:923-937 (1996).
16. Couldwell, W. T., J. P. Antel, and V. W. Yong. Protein kinase C activity correlates with the growth rate of malignant gliomas: Part II. Effects of glioma mitogens and modulators of protein kinase C. Neurosurgery 31: 717-724 (1992).
17. Couldwell, W. T., J. H. Uhm, J. P. Antel, and V. W. Yong. Enhanced protein kinase C activity correlates with the growth rate of malignant gliomas in vitro. Neurosurgery 29:880-887 (1991).
18. Pollack, I. F., M. S. Randall, M. P. Kristofik, R. H. Kelly, R. G. Selker, and F. T. Vertosick, Jr. Response of malignant glioma cell lines to activation and inhibition of protein kinase C-mediated pathways. J. Neurosurg. 73:98-105 (1990).
19. Baltuch, G. H., W. T. Couldwell, J. G. Villemure, and V. W. Yong. Protein kinase C inhibitors suppress cell growth in established and low-passage glioma cell lines: a comparison between staurosporine and tamoxifen. Neurosurgery 33:495-501 (1993).
20. Minana, M. D., V. Felipo, F. Cortes, and S. Grisolia. Inhibition of protein kinase C arrests proliferation of human tumors. FEBS. Lett. 284:60-62 (1991).
21. Misra-Press, A., A. P. Fields, D. Samols, and D. A. Goldthwait. Protein kinase C isoforms in human glioblastoma cells. Glia 6:188-197 (1992).
22. Shimosawa, S., T. Hachiya, M. Hagiwara, N. Usuda, K. Sugita, and H. Hidaka. Type-specific expression of protein kinase C isozymes in CNS tumor cells. Neurosci. Lett. 108:11-16 (1990).
23. Xiao, H., D. A. Goldthwait, and T. Mapstone. The identification of four protein kinase C isoforms in human glioblastoma cell lines: PKC alpha, gamma, epsilon, and zeta. J. Neurosurg. 81:734-740 (1994).
24. Matsumoto, T., E. Tani, I. Yamaura, K. Miyaji, and K. Kaba. Effects of protein kinase C modulation on multidrug resistance in human glioblastoma cells. Neurosurgery 36:565-572 (1995).
25. Todo, T., N. Shitara, H. Nakamura, K. Takakura, and K. Ikeda. Immunohistochemical demonstration of protein kinase C isozymes in human brain tumors. Neurosurgery 29:399-404 (1991).
26. Xu, J., S. Rockow, S. Kim, and W. Lei. Interferons block protein kinase C-dependent but not -independent activation of Raf-1 and mitogenactivated protein kinases and mitogenesis in NIH 3T3 cells. Mol. Cell. Biol. 14:8018-8027 (1994).
27. Nister, M., T. A. Libermann, C. Betsholtz, M. Pettersson, L. Claesson-Welsh, C. H. Heldin, J. Schlessinger, and B. Westermark. Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-α and their receptors in human malignant glioma cell lines. Cancer Res. 48:3910-3918 (1988).
28. Pollack, I. F., M. S. Randall, M. P. Kristofik, R. H. Kelly, R. G. Selker, and F. T. Vertosick, Jr. Response of low passage human malignant gliomas in vitro to stimulation and selective inhibition of growth factor-mediated pathways. J. Neurosurg. 75:284-293 (1991).
29. Ikemoto, H., E. Tani, T. Matsumoto, A. Nakano, and J.-I. Furuyama. Apoptosis of human glioma cells in response to calphostin C, a specific protein kinase C inhibitor. J. Neurosurg. 83:1008-1016 (1995).
30. Behrens, M. M., J. L. Martinez, C. Mortatilla, and J. Renart. Apoptosis induced by protein kinase C inhibition in a neuroblastoma cell line. Cell Growth Differ. 6:1375-1380 (1995).
31. Gavrieli, Y., Y. Sherman, and S. A. Ben-Sasson. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell biol. 119:493-501 (1992).
32. Goodson, C., K. S. Bell, and P. A. Insel. Inhibition of expression of protein kinase Ca by antisense cDNA inhibits phorbol ester-mediated arachidonate release. J. Biol. Chem. 266:11946-11950 (1993).
33. Voltek, A. B., and J. A. Cooper. Rho family members: activators of MAP kinase cascades. Cell 82:527-529 (1995).
34. Collard, J. G. Signaling pathways regulated by Rho-like proteins: a possible role in tumor formation and metastasis (Review). Int. J. Oncol. 8:131-138 (1996).